Showing results (1271-1280 of 5,257) with videos related to

Sort By:
Pageof 526
Oncology|September 4, 2024
Claudin-1 in Head and Neck Squamous Cell CarcinomaStefano Cavalieri, Cristiana Bergamini, Deborah Lenoci, et al.
Oncology|September 5, 2024
A Novel Index Including Age, Sex, hTERT, and Methylated RUNX3 Is Useful for Diagnosing Early Gastric CancerKatsuhiko Nakamura, Yutaka Suehiro, Koichi Hamabe, et al.
Oncology|August 26, 2024
Association of Insulin Receptor Substrate 1 Expression in the Prognosis of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-AnalysisDeeksheetha Prabhuvenkatesh, Pratibha Ramani, Monal B Yuwanati, et al.
Oncology|September 22, 2024
Application Value of Iodine-131 Combined with Levothyroxine Sodium in Patients with Differentiated Thyroid Cancer after SurgeryJinmiao Wang, Jie Hao, Ying Gao, et al.
Oncology|September 12, 2024
Clinical Impact of Skeletal Muscle Mass and Nutritional Status in Patients with Recurrent or Advanced Gastric Cancer Treated with NivolumabQingjiang Hu, Kensuke Kudo, Takafumi Yukaya, et al.
Oncology|September 12, 2024
Dose-Reduction of Bevacizumab in Atezolizumab plus Bevacizumab Therapy Extends Treatment duration with Disease Control in Patients with Hepatocellular CarcinomaMiwa Sakai, Hideki Iwamoto, Shigeo Shimose, et al.
Oncology|October 24, 2024
Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter StudyNobuhiro Nakazawa, Akihiko Sano, Yuji Kumakura, et al.
Oncology|October 13, 2024
Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World StudyMara Persano, Andrea Casadei-Gardini, Toshifumi Tada, et al.
Oncology|October 9, 2024
The Immune Microenvironment in Prostate Cancer: A Comprehensive ReviewRene Novysedlak, Miray Guney, Majd Al Khouri, et al.
Oncology|July 31, 2024
Chronic Lymphocytic Leukemia in Pregnancy: A Review of the Available Literature and the Pharmacological Challenges in ManagementAhmed Badr, Maria Benkhadra, Basel Elsayed, et al.
Pageof 526